Duragesic 25 mcg/hr CII pain patches recalled


DURAGESIC 25 mcg/hr (fentanyl transdermal system) CII patches for pain have been recalled because of a cut along one side of the drug reservoir within the patch. Fentanyl patches that are cut or damaged in any way may lead to serious adverse events.

The recalled patches all have expiration dates on or before December 2009, and all are manufactured by ALZA Corporation, an affiliate of PriCara. The recall is being conducted in cooperation with the U.S. Food and Drug Administration. All 25 mcg/hr fentanyl patches manufactured by ALZA and sold in Canada also are being recalled.

DURAGESIC 25 mcg/hr (fentanyl transdermal system) and Sandoz Inc. 25 mcg/hr fentanyl transdermal system patches being recalled may have a cut along one side of the drug reservoir within the patch. The result is possible release of fentanyl gel from the gel reservoir into the pouch in which the patch is packaged, exposing patients or caregivers directly to fentanyl gel. As per the approved product labeling for DURAGESIC, fentanyl is a potent Schedule II opioid medication.

Fentanyl patches that are cut or damaged in any way should not be used.

Exposure to fentanyl gel may lead to serious adverse events, including respiratory depression and possible overdose, which may be fatal. Anyone who comes in contact with fentanyl gel should thoroughly rinse exposed skin with large amounts of water only; do not use soap. Immediately dispose of affected patches with cut edges by flushing them down the toilet, using caution not to handle them directly. Patches with a cut edge that have leaked gel will not provide effective pain relief.

Anyone who has 25 mcg/hr DURAGESIC or Sandoz Inc. fentanyl patches should check the box or foil pouch for the expiration date to see if they have patches that are being recalled. The recalled patches all have expiration dates on or before December 2009. The cut edge in affected patches can be seen upon opening the sealed foil pouch that holds the patch. Affected patches should not be handled directly.

Anyone with 25 mcg/hr DURAGESIC patches being recalled should call 800-547-6446.

Anyone with 25 mcg/hr Sandoz Inc. patches being recalled should call 800-901-7236.

Patients using fentanyl patches who have medical questions should contact their health-care providers.

DUROGESIC? patches sold in Europe, Latin America and Asia are not affected by this recall.


(Editor compiled and published Duragesic 25 mcg/hr CII pain patches recalled at HealthNewsTrack on February 13, 2008 sourced from Ortho-McNeil - http://www.ortho-mcneil.com/)

Pain - recent articles and current news stories:

- Low back pain a major global disability
- Women specific chest pain symptoms not enough in heart attack diagnosis
- Acetaminophen pain drug can cause rare serious skin reactions
- Acupuncture may be better for chronic pain
- Painkillers like aspirin may protect against skin cancer

Most related articles:

- Duragesic 25 mcg/hr CII pain patches recalled
- Safety warning on fentanyl skin patch by US FDA - 7.1
- Oral HRT doubles risk of blood clots - 4.8
- FDA and CDC recommendations for consumers using peanut products - 4.6
- Aqua Leisure recalls inflatable baby floats - 3.9

More related articles:

- Duragesic, Pain patch, Fentanyl, Transdermal system, Pain
- Safety warning on fentanyl skin patch by US FDA - 19.6
- Ortho Evra contraceptive transdermal birth control patch label update - 9.6
- Sickle cell disease pain occurs daily - 7.7
- Pre cessation nicotine patch doubles quit success rate - 7.3

Pain related articles:

- Sickle cell disease pain occurs daily - 3.9
- TENS device for pain not recommended for chronic low back pain - 3.4
- Ginger consumption eases muscle pain by 25% - 3.4
- Low back pain lumbar supports not reducing sick leave - 3.3
- Women specific chest pain symptoms not enough in heart attack diagnosis - 3.3

Pain article/news source:

Read more health articles from Ortho-McNeil and health articles from USA.

Pain - search related terms:

Duragesic, Fentanyl, Pain, Pain patch, Transdermal system,
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Subscribe: rss | email

Top sections:
Health (188)
Breast cancer (168)
Healthcare (134)
HIV (129)
Obesity (126)
Pregnancy (114)
Diabetes (101)
Swine Flu (97)
Prostate Cancer (86)
Heart disease (84)
Smoking (81)
Alzheimer's Disease (79)
Cancer (75)
Depression (61)
Autism (52)


Current news
PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. said that all lots of 25 microgram/hour (mcg/hr) DURAGESIC (fentanyl transdermal system) CII patches sold by PriCara in the United States and all 25 mcg/hr fentanyl patches sold by Sandoz Inc. in the United States are being voluntarily recalled as a precaution from wholesalers and pharmacies.

What is Pain?
About Pain -- Pain is a universal human experience. The International Association for the Study of Pain (IASP) defines pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage." Pain may be a symptom of an underlying disease or disorder, or a disorder in its own right.


List health news, Health organizations, Health news world, Glossary     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2014 HealthNewstrack.com
0.2